VHT · Vanguard Health Care Index Fund
VHT tracks the Health Care and returned +21.6% over the past year.
Key facts
Its ten largest equity positions
| Holding | Weight | |
|---|---|---|
| Eli Lilly & Co | 14.07% | |
| Johnson & Johnson | 8.48% | |
| AbbVie Inc | 6.10% | |
| UnitedHealth Group Inc | 5.46% | |
| Merck & Co Inc | 4.67% | |
| Thermo Fisher Scientific Inc | 2.93% | |
| Amgen Inc | 2.87% | |
| Gilead Sciences Inc | 2.64% | |
| Intuitive Surgical Inc | 2.39% | |
| Pfizer Inc | 2.36% |
Compare VHT
Also against BINC, BITO, BND, BNDX, BOND, BOXX, BSV, BWET, CGBL, CGDV, CGGR, COWZ, CTA, DBMF, DFUS, DGRO, DGRW, DIA, DVY, DYNF, EDV, EEM, EFA, EMB, EMXC, EWJ, EWT, EWY, EWZ, EZU, FBCG, FDVV, FENI, FLKR, FNDX, FTEC, FXI, GARP, GLD, GLDM, GOVT, GRNY, HDV, HGER, HYG, HYMB, IALT, IAU, IBB, IDEV, IEF, IEFA, IEI, IEMG, IGIB, IGM, IGSB, IJH, IJR, IJS, IJT, ILF, INDA, ITOT, IUSB, IVV, IWB, IWC, IWD, IWF, IWM, IWO, IXUS, IYE, IYR, IYW, JAAA, JNK, KRE, LQD, MAGS, MBB, MDY, MGK, MINT, MOAT, MTUM, MUB, NOBL, ONEQ, PDBC, PFF, PULS, PVAL, QQQ, QQQM, QUAL, RDVY, RSP, SCHB, SCHD, SCHF, SCHG, SCHH, SCHP, SCHX, SDY, SGOV, SHV, SHY, SIVR, SLV, SPHD, SPHQ, SPLG, SPMO, SPSB, SPY, SPYD, SPYG, TIP, TLT, URTH, USFR, USHY, USMV, USO, VB, VBIL, VBK, VBR, VCIT, VCLT, VCSH, VDC, VDE, VEA, VEU, VGIT, VGK, VGLT, VGSH, VGT, VIG, VLUE, VNQ, VO, VOE, VONG, VOO, VOOG, VOX, VPL, VPU, VT, VTEB, VTI, VTIP, VTV, VTWO, VUG, VUSB, VWO, VXF, VXUS, VYM, VYMI, XBI, XHB, XLB, XLC, XLE, XLF, XLG, XLI, XLK, XLP, XLRE, XLU, XLV, XLY, XOP, XOVR, XRT.
Period by period
| Window | Total return | S&P 500 | Gap to S&P 500 | Gap to Nasdaq-100 |
|---|---|---|---|---|
| 3 months | +8.8% | +3.3% | +5.5 pts | +9.6 pts |
| 6 months | +13.1% | +16.0% | −2.9 pts | −7.6 pts |
| 1 year | +21.6% | +17.5% | +4.1 pts | −1.4 pts |
| 3 years | +33.9% | +77.9% | −44.0 pts | −61.2 pts |
| Since listing | +618.1% | +804.4% | −186.3 pts | −1055.8 pts |
In plain words
VHT is an index equity fund tracking the Health Care. Over the year to Sep 11, 2026 it returned +21.6% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.09% a year. By its holdings filed for May 31, 2026, 86% of the fund by weight is stocks the S&P 500 also holds, across 401 positions, with the top ten at 52.0%. It sat 5.7% below its high of Aug 19, 2026 on Sep 11, 2026.
| What it tracks | Health Care |
|---|---|
| Fund type | Index equity fund |
| Expense ratio (485BPOS XBRL, Dec 19, 2025) | 0.09% |
| Price | $310.74 |
| Listed since | Jan 4, 2010 |
| Net assets (SEC filing, whole fund, as filed for May 31, 2026) | $19.0bn |
| Below its high (ETFIQ) | −5.7% |
| Holdings | 401 |
| Top ten weight | 52.0% |
| Holdings as of (SEC N-PORT) | May 31, 2026 |
| Already in the S&P 500, by weight (ETFIQ) | 85.6% |
| Active share vs the S&P 500 (ETFIQ) | 91.1% |
| Already in the Nasdaq-100, by weight (ETFIQ) | 13.3% |
Questions people ask
- How has VHT performed?
- Over the year to Sep 11, 2026, VHT returned +21.6% with distributions reinvested, against +17.5% for the S&P 500. Over three years the figure is +33.9%.
- What does VHT cost?
- The prospectus expense ratio is 0.09% a year.
- What does VHT hold?
- 401 positions as filed for May 31, 2026, with the top ten at 52.0% of the fund. 86% of its weight is in stocks the S&P 500 also holds.
- How far is VHT below its high?
- 5.7% below its high of Aug 19, 2026, measured on the reinvested series to Sep 11, 2026.
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Funds near this one
Cite this page. ETFIQ, VHT, core index fund, data as of Sep 11, 2026. https://etfiq.com/funds/VHT Free to use with attribution; the underlying files are at Open data.
ETFIQ covers leveraged and inverse, thematic, buffer, option-income, core index and spot crypto ETFs. This fund is here because the other funds here are measured against it and portfolios hold it. ETFIQ is an independent publisher and makes no recommendations. Standards and sources